Free Trial
NYSE:MED

MEDIFAST (MED) Stock Price, News & Analysis

MEDIFAST logo
$13.76 -0.04 (-0.25%)
As of 10:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MEDIFAST Stock (NYSE:MED)

Key Stats

Today's Range
$13.69
$13.84
50-Day Range
$12.77
$15.22
52-Week Range
$11.57
$21.98
Volume
11,388 shs
Average Volume
221,265 shs
Market Capitalization
$151.28 million
P/E Ratio
43.02
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Hold

Company Overview

MEDIFAST Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
86th Percentile Overall Score

MED MarketRank™: 

MEDIFAST scored higher than 86% of companies evaluated by MarketBeat, and ranked 38th out of 144 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MEDIFAST has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    MEDIFAST has a consensus price target of $16.50, representing about 19.4% upside from its current price of $13.82.

  • Amount of Analyst Coverage

    MEDIFAST has received no research coverage in the past 90 days.

  • Read more about MEDIFAST's stock forecast and price target.
  • Earnings Growth

    Earnings for MEDIFAST are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MEDIFAST is 43.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 279.22.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MEDIFAST is 43.19, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 18.25.

  • Price to Book Value per Share Ratio

    MEDIFAST has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about MEDIFAST's valuation and earnings.
  • Percentage of Shares Shorted

    19.48% of the float of MEDIFAST has been sold short.
  • Short Interest Ratio / Days to Cover

    MEDIFAST has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in MEDIFAST has recently decreased by 10.92%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MEDIFAST does not currently pay a dividend.

  • Dividend Growth

    MEDIFAST does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    19.48% of the float of MEDIFAST has been sold short.
  • Short Interest Ratio / Days to Cover

    MEDIFAST has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in MEDIFAST has recently decreased by 10.92%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MEDIFAST has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.92 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for MEDIFAST this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    3 people have added MEDIFAST to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MEDIFAST insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,003.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.90% of the stock of MEDIFAST is held by insiders.

  • Percentage Held by Institutions

    95.51% of the stock of MEDIFAST is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about MEDIFAST's insider trading history.
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MEDIFAST and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MED Stock News Headlines

Reviewing MEDIFAST (NYSE:MED) and GLG Life Tech (OTCMKTS:GLGLF)
Wall Street legend: “Put $1,000 in this AI stock”
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW kind of AI stock.tc pixel
Why Medifast (MED) Stock Is Trading Up Today
See More Headlines

MED Stock Analysis - Frequently Asked Questions

MEDIFAST's stock was trading at $17.62 at the beginning of 2025. Since then, MED shares have decreased by 21.6% and is now trading at $13.82.

MEDIFAST INC (NYSE:MED) posted its earnings results on Monday, August, 4th. The specialty retailer reported $0.04 earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.26. The specialty retailer earned $105.56 million during the quarter, compared to analyst estimates of $96.10 million. MEDIFAST had a net margin of 0.76% and a trailing twelve-month return on equity of 2.00%.
Read the conference call transcript
.

MEDIFAST's top institutional shareholders include Acadian Asset Management LLC (3.74%), Bank of America Corp DE (3.61%), Geode Capital Management LLC (2.31%) and American Century Companies Inc. (1.95%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends
.

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MEDIFAST investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
8/04/2025
Today
9/09/2025
Next Earnings (Estimated)
11/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
FOOD - MISC/DIVERSIFIED
Sub-Industry
Personal Products
Current Symbol
NYSE:MED
CIK
910329
Employees
870
Year Founded
1981

Price Target and Rating

High Price Target
$16.50
Low Price Target
$16.50
Potential Upside/Downside
+19.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.32
Trailing P/E Ratio
43.19
Forward P/E Ratio
27.10
P/E Growth
N/A
Net Income
$2.09 million
Net Margins
0.76%
Pretax Margin
1.30%
Return on Equity
2.00%
Return on Assets
1.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.47
Quick Ratio
3.82

Sales & Book Value

Annual Sales
$602.46 million
Price / Sales
0.25
Cash Flow
$2.93 per share
Price / Cash Flow
4.71
Book Value
$19.21 per share
Price / Book
0.72

Miscellaneous

Outstanding Shares
10,990,000
Free Float
10,672,000
Market Cap
$151.88 million
Optionable
Optionable
Beta
0.82

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:MED) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners